Professional Documents
Culture Documents
نسخة MHN - CASE STUDY Schizoeffective (Repaired)
نسخة MHN - CASE STUDY Schizoeffective (Repaired)
Ministry Of Health
Case Study
Schizoaffective disorder
Submitted by:
Based on the patient her grandmother has There are no mental illness in the patient family
hypertension and died from it.
Admission Present
Insomnia
Tiredness
Poor self-care AEB patient has bad odor.
Physical (2) Poor self-hygiene
Scaly patches, red skin, and stubborn
Poor sleeping
dandruff in the scalp and under the ears.
1- Haloperidol (Injection) As the nurse said that they use Family therapy
2- Promethazine (Injection) exercises as physical therapy
3- Olanzapine (Tablet) for the patients.
4- Clonazepam (Tablet)
5- Procyclidine (Tablet) ECT
6- Sodium Valproate (Tablet)
III. Review of Literature of Present Mental Illness and the Treatment Received (6 marks)
Literature Patient
Genetic (The patient has anatomical
Genetic
abnormality (micro adenoma in
Biochemical influences
pituitary gland)).
Physiological influences
Etiology (2) Environmental influences (The patient
Psychological aspects
lived in stressful life event, her
Environmental influences
condition worsen when one of her
Theoretical Integration
sisters get engage, so she fell joules).
Signs and Positive symptoms: Positive symptoms:
Symptoms (2) 1- Content of thought: 1- Content of thought: Delusions
Delusions, religiosity, paranoia, (paranoid), Paranoia (joules type).
magical thinking.
2- Form of thought: Circumstantiality
2- Form of thought: (Ask the patient one question in
Associative looseness, neologisms, different ways to get the answer).
concrete thinking, clang association,
ward salad, circumstantiality, 3- Perception:
tangentiality, mutism, and Patient does not has hallucinations or
perseveration. illusions.
Negative symptoms:
4- Sense of self: 1- Affect: Inappropriate affect (patient
Echolalia, echopraxia, identification
and imitation, depersonalization.
Name of
No Classification Dose Route Frequency Action Possible side effects Nurse’s Responsibilities
Drug/Generic
. (1 mark) (1 mark) (1 mark) (1 mark) (1 mark) (2 Marks) (2 marks)
(1 mark)
Alters the Seizures, drowsiness, 1- Be alert for new
effects of restlessness, tardive seizures or increased
dopamine in the dyskinesia, blurred seizure activity,
Haloperidol Antipsychotic 5 Mg IM SOS CNS. Also has vision, dry eyes, especially at the onset of
anticholinergic respiratory depression, drug treatment.
and alpha- hypotension, tachycardia, 2- Monitor signs of
1 adrenergic urinary retention, hypersensitivity
blocking amenorrhea, anemia, reactions.
activity. neuroleptic malignant 3-Assess BP periodically,
Diminished syndrome, assesses heart rate, ECG,
signs and hypersensitivity and heart sounds.
symptoms of reactions.
psychoses.
Blocks the Neuroleptic malignant 1- Monitor and report
effects of syndrome, confusion, signs of neuroleptic
Promethazine Antiemetics, 25 Mg IM SOS histamine. Has disorientation, sedation, malignant syndrome.
Antihistamines an inhibitory dizziness, extrapyramidal 2- Assess motor function,
Sedative/ effect on the reactions, fatigue, and be alert for
hypnotics chemoreceptor insomnia, nervousness, extrapyramidal reactions.
trigger zone in blurred vision, diplopia, 3- Monitor unusual
2 the medulla, tinnitus, bradycardia, weakness and fatigue that
resulting in hypertension, might be due to anemia.
antiemetic hypotension, tachycardia, 4- Assess dizziness and
properties. constipation, drug- drowsiness that might
Alters the induced hepatitis, dry affect gait, balance, and
effects of mouth, photosensitivity, other functional
dopamine in the rashes, blood dyscrasias. activities.
CNS.
Antagonizes Neuroleptic malignant 1- Monitor and report
dopamine and syndrome, seizures, signs of neuroleptic
Olanzapine Antipsychotics 20 Mg Oral HS serotonin type 2 dizziness, insomnia, malignant syndrome.
Mood stabilizers in the CNS. mood changes, 2- Be alert for new
Also has personality disorder, seizures or increased
3
anticholinergic, tardive dyskinesia, seizure activity.
antihistaminic, dyspnea, orthostatic 3- Assess heart rate,
and anti–alpha1- hypotension, tachycardia, ECG, and heart sounds,
adrenergic constipation, dry mouth, and Assess BP.
effects. nausea, tremor.
Produces Behavioral changes, 1- Monitor daytime
sedative effects drowsiness, fatigue, drowsiness.
Clonazepam Anticonvulsants 0.5 Mg Oral BID in the CNS, by slurred speech, 2- Assess balance and
stimulating nystagmus, palpitations, risk of falls
4 inhibitory constipation/ diarrhea, 3-Monitor unusual
gamma-amino dysuria, anemia, weakness and fatigue that
butyric acid leukopenia, might be due to anemia.
receptors. thrombocytopenia,
ataxia.
Inhibits neuronal Anxiety, insomnia, 1- Check the vital signs
reuptake of weakness, impaired RR,PR and BP and report
5 Mg Oral BID serotonin in the concentration, mental for any abnormality
Procyclidine Antianxiety CNS, thus depression, blurred 2- Check if the patient
agents potentiating the vision, chest pain, have any allergy from the
Antidepressants activity of
edema, palpitations, medication
serotonin; has
5 little effect on orthostatic hypotension, 3- Assess blood pressure
norepinephrine or tachycardia, vasodilation, (BP) periodically and
dopamine. nausea, decreased compare to normal
appetite, dyspepsia, values and Report a
flatulence, sweating, sustained increase in BP.
pruritus, weight gain/
loss, myalgia, tremor.
Increase levels SUICIDAL 1- Watch for signs of
of gamma- THOUGHTS, dizziness, hepatotoxicity or
amino butyric headache, insomnia, pancreatitis.
Sodium Anticonvulsants 1500 Mg Oral Split dose acid (GABA), confusion, depression, 2- Be alert for suicidal
Valproate (Mood an inhibitory peripheral edema, visual thoughts and ideology;
stabilizer) neurotransmitter disturbances, notify the physician
in the CNS HEPATOTOXICITY, immediately if the patient
PANCREATITIS, exhibits signs of
abdominal pain, depression or other
anorexia, diarrhea/ changes in mood and
constipation, increased behavior.
6
appetite, alopecia, rashes, 3- Be alert for signs of
weight gain, increased ammonia levels
thrombocytopenia, (hyperammonemia).
HYPERAMMONEMIA, 4- Assess dizziness,
HYPOTHERMIA, ataxia, or tremor that
tremor, ataxia might affect gait,
balance, and other
functional activities.
5- Monitor daytime
drowsiness, confusion, or
anxiety.
Summary:
Electroconvulsive therapy (ECT) is an effective treatment for many depressive disorders, and it less
treatment of used for psychotic disorders. The last literature shows that ECT can be a useful strategy
for a lot of psychotic disorders, including treatment-resistant schizophrenia. The aim of this review is
to test the literature of ECT to treat schizophrenia with an initial focus on the effectiveness of it, its
impact on cognitive function, the role of maintenance ECT, and the potential role of neuroimaging
biomarkers to provide more precise ECT treatment strategies. In this review, they evaluate the
literature about ECT strategy to treat schizophrenia in a safe manner, but they should to be attention
that the ECT may cause cognitive impairment so they must always be careful. They did several
studies to explore the effectiveness of ECT as a physical treatment for schizophrenia, and they found
that patients who treated with ECT had significantly reduced rates of psychiatric hospitalization
during the post-treatment period. This effect was more pronounced in patients treated with higher
doses of antipsychotics or with clozapine.
It relates to my patient that they use Electroconvulsive therapy (ECT) to reduce the symptoms of
schizoaffective disorder and to treat it, and it was effective for her as she had reduced her psychiatric
hospitalization as the last hospitalization for her 5 months ago, and she uses antipsychotics
medications.
Date: _______________________